25 /100
LOW RISK
Score updated May 30, 2026

TBPH — Theravance Biopharma, Inc. Dilution Risk Tracker

Track TBPH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TBPH — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
60
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
20%
🔁 Convertible Conversion 40%
• Significant convertible debt: 28% potential dilution
• Elevated convertible risk (60/100)
🔔 Track TBPH — Get forecast alerts →

💹 Market Data

Market Cap$827.94M
Shares Outstanding51.55M
Float23.70M
Cash$394.67M
Debt$40.50M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 1.5% shares (2025Q4 vs prior)
168 institutional holders · 50.50M shares
#1 Madison Avenue Partners, LP 9.51M shares
#2 Weiss Asset Management LP 7.46M shares
#3 Newtyn Management, LLC 4.30M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.99M
Days to Cover14.8
% of Float21.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Jun 30, 2022
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track TBPH Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TBPH — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for TBPH
📊 TBPH FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TBPH Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.